| 1 |
Fass R, Boeckxstaens GE, El-Serag H, et al. Gastro-oesophageal reflux disease [J]. Nat Rev Dis Primers, 2021, 7(1): 55.
|
| 2 |
Sharma P, Yadlapati R. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid [J]. Ann N Y Acad Sci, 2021, 1486(1): 3-14.
|
| 3 |
El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review [J]. Gut, 2014, 63(6): 871-880.
|
| 4 |
张玲, 邹多武. 胃食管反流病的流行病学及危险因素 [J].临床荟萃, 2017, 32(1): 1-4.
|
| 5 |
Mikami DJ, Murayama KM. Physiology and pathogenesis of gastroesophageal reflux disease[J]. Surg Clin North Am, 2015, 95(3): 515-525.
|
| 6 |
Zhang M, Hou ZK, Huang ZB, et al. Dietary and lifestyle factors related to gastroesophageal reflux disease: a systematic review [J]. Ther Clin Risk Manag, 2021, 17: 305-323.
|
| 7 |
Taraszewska A. Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet [J]. Rocz Panstw Zakl Hig, 2021, 72(1): 21-28.
|
| 8 |
Zhou C, Li M, Liu L, et al. Food consumption and dietary patterns of local adults living on the Tibetan plateau: results from 14 countries along the Yarlung Tsangpo River [J]. Nutrients, 2021, 13(7): 2444.
|
| 9 |
Wu XY, Hu C, Wong KKF, et al. Gastrointestinal motility disorders at high altitude: a systematic review [J]. High Alt Med Biol, 2020, 21(3): 214-225.
|
| 10 |
Li M, Zhao F, Zhang X, et al. Prevalence and risk factors of gastroesophageal reflux disease in Qinghai plateau: a cross-sectional study [J]. J Dig Dis, 2023, 24(5): 372-380.
|
| 11 |
Zhang H, Gao W, Wang L, et al. A population-based study on prevalence and risk factors of gastroesophageal reflux disease in the Xizang Autonomous Region, China [J]. PeerJ, 2019, 7: e6491.
|
| 12 |
Kumar S, Sharma S, Norboo T, et al. Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area [J]. Indian J Gastroenterol, 2011, 30(3): 135-143.
|
| 13 |
Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care [J]. Aliment Pharmacol Ther, 2009, 30(10): 1030-1038.
|
| 14 |
Simadibrata DM, Ngadiono E, Sinuraya FAG, et al. Diagnostic accuracy of gastroesophageal reflux disease questionnaire for gastroesophageal reflux disease: a systematic review and meta-analysis [J]. Neurogastroenterol Motil, 2023, 35(12): e14619.
|
| 15 |
AbuDujain NM, Batais MA, Muqresh MA, et al. Translation, cultural adaptation, and evaluation of the psychometric properties of the Arabic Gastroesophageal Reflux Disease Questionnaire (Ar-GerdQ) [J]. Saudi J Gastroenterol, 2024, 30(6): 369-375.
|
| 16 |
Suzuki H, Matsuzaki J, Okada S, et al. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan [J]. United European Gastroenterol J, 2013, 1(3): 175-183.
|
| 17 |
Gong EJ, Jung KW, Min YW, et al. Validation of the Korean Version of the gastroesophageal reflux disease questionnaire for the diagnosis of gastroesophageal reflux disease [J]. J Neurogastroenterol Motil, 2019, 25(1): 91-99.
|
| 18 |
Vadivelu S, Ma ZF, Ong EW, et al. Clinical validity and reliability of the Malay language translations of gastroesophageal reflux disease questionnaire and quality of life in reflux and dyspepsia questionnaire in a primary care setting [J]. Dig Dis, 2019, 37(2): 100-107.
|
| 19 |
Chapelle N, Ben Ghezala I, Barkun A, et al. The pharmacotherapeutic management of gastroesophageal reflux disease (GERD) [J]. Expert Opin Pharmacother, 2021, 22(2): 219-227.
|
| 20 |
Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD consensus conference participants. AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review [J]. Clin Gastroenterol Hepatol, 2022, 20(5): 984-994.e1.
|
| 21 |
El-Serag HB, Thrift AP. Obesity and gastroesophageal reflux disease[M]. In: Richter JE, Castell DO, Katzka DA, et al, eds. The Esophagus. 5th ed. Wiley-Blackwell, 2021: Chapter 36.
|
| 22 |
Fass R. Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment [J]. J Clin Gastroenterol, 2007, 41(5): 437-444.
|
| 23 |
Zhang M, Liang M, Chen S, et al. Novel physiologic nomogram discriminates symptom outcome in patients with erosive esophagitis [J]. Esophagus, 2021, 18(2): 407-415.
|
| 24 |
Jin L, Huang XK, Gao ZY, et al. Development and validation of a novel nomogram to predict worsening of gastroesophageal reflux symptoms after laparoscopic sleeve gastrectomy using Lasso-logistic regression [J]. Sci Rep, 2024, 14(1): 25427.
|
| 25 |
Cao H, Yin H, Li L, et al. Low pillow height is associated with LPR among patients with GERD: a retrospective single-center study [J]. BMC Gastroenterol, 2025, 25(1): 778.
|
| 26 |
Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification [J]. Gut, 1999, 45(2): 172-180.
|
| 27 |
Ghoneim S, Wang J, El Hage Chehade N, et al. Diagnostic accuracy of the proton pump inhibitor test in gastroesophageal reflux disease and noncardiac chest pain: a systematic review and meta-analysis [J]. J Clin Gastroenterol, 2023, 57(4): 380-388.
|
| 28 |
Hurr TJ. The six-question gastroesophageal reflux disease questionnaire (GerdQ) cannot accurately quantify reflux and reflux-associated symptoms frequency [J]. Gastroenterol Rep (Oxf), 2022, 10: goac043.
|
| 29 |
Riley RD, Ensor J, Snell KIE, et al. Calculating the sample size required for developing a clinical prediction model [J]. BMJ, 2020, 368: m441.
|
| 30 |
Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders [J]. Gastroenterology, 2006, 130(5): 1466-1479.
|
| 31 |
Kuo CH, Wu LL, Chen HP, et al. Direct effects of alcohol on gut-epithelial barrier: unraveling the disruption of physical and chemical barrier of the gut-epithelial barrier that compromises the host-microbiota interface upon alcohol exposure [J]. J Gastroenterol Hepatol, 2024, 39(7): 1247-1255.
|
| 32 |
Elliott JA, Reynolds JV. Visceral obesity, metabolic syndrome, and esophageal adenocarcinoma [J]. Front Oncol, 2021, 11: 627270.
|